SCHEMBL7047495

SCHEMBL7047495

CC1(C)Oc2ccc(C(=O)CO)cc2[C@H](NC(=O)c2cc(F)cc(F)c2)[C@H]1O

nearest known ligand 0.67

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ABCC9 O60706 5/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7045282 0.93 ABCC9 (0.59) ABCC9
Tidembersat SCHEMBL1231138 0.88 ABCC9 (0.58) ABCC9
SCHEMBL7044135 0.86 ABCC9 (0.59) ABCC9
SCHEMBL7475685 0.84 ABCC9 (0.59) ABCC9
SCHEMBL7477937 0.84 ABCC9 (0.59) ABCC9
SCHEMBL7475675 0.84 ABCC9 (0.59) ABCC9
SCHEMBL7481173 0.81 ABCC9 (0.66) ABCC9
SCHEMBL7482702 0.81 ABCC9 (0.66) ABCC9
SCHEMBL7481178 0.81 ABCC9 (0.66) ABCC9
Carabersat SCHEMBL3301553 0.80 ABCC9 (0.62) ABCC9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117364539-A Degradable full-biological-based laminated paper for food, preparation method and application 安徽金普瑞新材料有限公司 2024-01-09 CN claimed
EP-1091950-B1 SUBSTITUTED BENZOPYRAN DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 2003-04-09 EP claimed
US-6395909-B1 DRUGS FOR ANTICONVULSANTS SMITHKLINE BEECHAM P.L.C. (GB) 2002-05-28 US claimed
EP-1091950-A1 SUBSTITUTED BENZOPYRAN DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 2001-04-18 EP claimed
WO-2000000484-A1 SUBSTITUTED BENZOPYRAN DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 2000-01-06 WO claimed
CN-117364539-A Degradable full-biological-based laminated paper for food, preparation method and application 安徽金普瑞新材料有限公司 2024-01-09 CN disclosed
CN-117364539-A Degradable full-biological-based laminated paper for food, preparation method and application 安徽金普瑞新材料有限公司 2024-01-09 CN disclosed
US-6617478-B2 Preparing a catalyst by adding an alkaline precipitator to an aqueous copper salt solution to form copper hydroxide particles, aging the particles following the addition of silica sol, activating the catalyst by reduction with hydrogen SAMSUNG ELECTRONICS CO., LTD. (KR) 2003-09-09 US disclosed
US-6617477-B2 Using a hydrogenation catalyst prepared by adding an alkaline precipitator to an aqueous solution containing a copper salt to form particles, and then aging the particles following addition of colloidal silica SAMSUNG ELECTRONICS CO., LTD. (KR) 2003-09-09 US disclosed
EP-1308431-A2 Process for preparing 1,3-alkandiols from 3-hydroxyester SAMSUNG ELECTRONICS CO., LTD. (KR) 2003-05-07 EP disclosed
US-20030069456-A1 Preparing a catalyst by adding an alkaline precipitator to an aqueous copper salt solution to form copper hydroxide particles, aging the particles following the addition of silica sol, activating the catalyst by reduction with hydrogen SAMSUNG ELECTRONICS CO., LTD. AND 2003-04-10 US disclosed
EP-1091950-B1 SUBSTITUTED BENZOPYRAN DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 2003-04-09 EP disclosed
EP-1211234-A2 Process for preparing 1,3-alkandiols from 3-hydroxyesters SAMSUNG ELECTRONICS CO., LTD. (KR) 2002-06-05 EP disclosed
US-6395909-B1 DRUGS FOR ANTICONVULSANTS SMITHKLINE BEECHAM P.L.C. (GB) 2002-05-28 US disclosed
EP-1091950-A1 SUBSTITUTED BENZOPYRAN DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 2001-04-18 EP disclosed
WO-2000000484-A1 SUBSTITUTED BENZOPYRAN DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 2000-01-06 WO disclosed
EP-0580336-B1 Process for preparing optically active 4-methyl-2-oxetanone TAKASAGO PERFUMERY CO LTD (JP) 1998-09-30 EP disclosed
US-5412109-A Process for preparing optically active 4-methyl-2-oxetanone TAKASAGO INTERNATIONAL CORPORATION (JP) 1995-05-02 US disclosed
US-5306834-A Catalytic hydrogenation of 4-methylene-2-oxetanone TAKASAGO INTERNATIONAL CORPORATION (JP) 1994-04-26 US disclosed
EP-0580336-A1 Process for preparing optically active 4-methyl-2-oxetanone TAKASAGO INTERNATIONAL CORPORATION (JP) 1994-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030069456-A1 Preparing a catalyst by adding an alkaline precipitator to an aqueous copper salt solution to form copper hydroxide particles, aging the particles following the addition of silica sol, activating the catalyst by reduction with hydrogen APEH, HAO2, AP1G1 ABCC9 4373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.